Literature DB >> 17354474

[The epidemiology of hemolytic uremic syndrome in Argentina. Diagnosis of the etiologic agent, reservoirs and routes of transmission].

Marta Rivas1, Elizabeth Miliwebsky, Isabel Chinen, Natalia Deza, Gerardo A Leotta.   

Abstract

Shiga toxin-producing Escherichia coli (STEC) cause sporadic cases and outbreaks of nonbloody and bloody diarrhea, and hemolytic uremic syndrome (HUS). E. coil O157:H7 is the most prevalent STEC serotype. However, other serotypes (O26:H11; O103:H2; O111:NM; O121:H19; O145:NM, among others) can cause a similar disease spectrum. Shiga toxins (Stx1, Stx2, and their variants), intimin, and enterohemolysin are the main virulence factors. Three different diagnostic criteria are used to determine the frequency of STEC infection: 1) isolation and characterization of STEC strains; 2) detection of specifically neutralizable free fecal Stx; and 3) Serological tests to detect Stx-antibodies. The surveillance of the STEC strains is performed using subtyping techniques: a) genotyping of Stx and eae by PCR-RFLP; b) phage typing of E. coil O157 strains; and c) pulsed-field gel electrophoresis. STEC O157 and non-O157 strains are recovered from clinic, animal, food and environmental samples, and E. coli O157:H7, a Stx2 and Stx2c producer, harboring eae and ehxA genes, is the most common serotype. During a prospective case-control study conducted to evaluate risk factors for sporadic STEC infection in Mendoza Province and Buenos Aires City and its surroundings during 2001-2002, exposures associated with risk included eating undercooked beef, contact with a child < 5 years with diarrhea and living in or visiting a place with farm animals. Both washing hands after handling raw beef, and eating fruits and vegetables were frequently protective. Strategies of prevention and control are necessary to decrease the incidence of STEC infections in Argentina.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17354474

Source DB:  PubMed          Journal:  Medicina (B Aires)        ISSN: 0025-7680            Impact factor:   0.653


  39 in total

1.  Seasonal variation of HUS occurrence and VTEC infection in children with acute diarrhoea from Argentina.

Authors:  M A Rivero; J A Passucci; E M Rodríguez; A E Parma
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-09-22       Impact factor: 3.267

2.  Immunoproteomic analysis to identify Shiga toxin-producing Escherichia coli outer membrane proteins expressed during human infection.

Authors:  David Montero; Paz Orellana; Daniela Gutiérrez; Daniela Araya; Juan Carlos Salazar; Valeria Prado; Angel Oñate; Felipe Del Canto; Roberto Vidal
Journal:  Infect Immun       Date:  2014-08-25       Impact factor: 3.441

3.  Antibiogram of E. coli serotypes isolated from children aged under five with acute diarrhea in Bahir Dar town.

Authors:  Ayrikim Adugna; Mulugeta Kibret; Bayeh Abera; Endalkachew Nibret; Melaku Adal
Journal:  Afr Health Sci       Date:  2015-06       Impact factor: 0.927

4.  Development and Evaluation of a Novel VHH-Based Immunocapture Assay for High-Sensitivity Detection of Shiga Toxin Type 2 (Stx2) in Stool Samples.

Authors:  Luciano J Melli; Vanesa Zylberman; Yanina Hiriart; Constanza E Lauche; Ariela Baschkier; Romina Pardo; Elizabeth Miliwebsky; Isabel Chinen; Marta Rivas; Fernando A Goldbaum; Juan E Ugalde; Diego J Comerci; Andrés E Ciocchini
Journal:  J Clin Microbiol       Date:  2020-02-24       Impact factor: 5.948

5.  Oral administration of Shiga toxin-producing Escherichia coli induces intestinal and systemic specific immune response in mice.

Authors:  Romina Jimena Fernandez-Brando; Gabriel Cabrera; Ariela Baschkier; María Pilar Mejías; Cecilia Analia Panek; Elizabeth Miliwebsky; María Jimena Abrey-Recalde; Leticia Verónica Bentancor; María Victoria Ramos; Marta Rivas; Marina Sandra Palermo
Journal:  Med Microbiol Immunol       Date:  2014-01-08       Impact factor: 3.402

6.  A DNA vaccine encoding the enterohemorragic Escherichia coli Shiga-like toxin 2 A2 and B subunits confers protective immunity to Shiga toxin challenge in the murine model.

Authors:  Leticia V Bentancor; Marcos Bilen; Romina J Fernández Brando; María Victoria Ramos; Luis C S Ferreira; Pablo D Ghiringhelli; Marina S Palermo
Journal:  Clin Vaccine Immunol       Date:  2009-01-28

7.  Characteristics and outcome of hemolytic uremic syndrome in Sudanese children in a single Centre in Khartoum State.

Authors:  Eltigani Mohamed Ahmed Ali; Nagmelddin Mohamed Abbakar; Mohamed Babikir Abdel Raheem; Rashid Abdelrahman Ellidir
Journal:  Sudan J Paediatr       Date:  2017

8.  Bovine colostrum contains immunoglobulin G antibodies against intimin, EspA, and EspB and inhibits hemolytic activity mediated by the type three secretion system of attaching and effacing Escherichia coli.

Authors:  Daniel A Vilte; Mariano Larzábal; Angel A Cataldi; Elsa C Mercado
Journal:  Clin Vaccine Immunol       Date:  2008-06-18

9.  Role of TNF-α in the mechanisms responsible for preterm delivery induced by Stx2 in rats.

Authors:  Juliana Burdet; Flavia Sacerdoti; Maximiliano Cella; Ana M Franchi; Cristina Ibarra
Journal:  Br J Pharmacol       Date:  2013-02       Impact factor: 8.739

10.  Multilocus genotype analysis of Escherichia coli O157 isolates from Australia and the United States provides evidence of geographic divergence.

Authors:  Glen E Mellor; Thomas E Besser; Margaret A Davis; Brittany Beavis; Wookyung Jung; Helen V Smith; Amy V Jennison; Christine J Doyle; P Scott Chandry; Kari S Gobius; Narelle Fegan
Journal:  Appl Environ Microbiol       Date:  2013-06-14       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.